Kvirkvelia N, Shakarishvili R, Kanashvili T
I. Javakhishvili Tbilisi State University, P. Sarajishvili Institute of Neurology, Georgia.
Georgian Med News. 2018 Mar(276):86-92.
The authors present a case of 75-year-old male patient with typical clinical and electroneuromyographic signs of Amyotrophic Lateral Sclerosis (ALS), manifested in 4 years after a diagnosis of generalized Myasthenia Gravis (MG) had been made. The aim of the article is to assess the possibility of pathogenetic integrated comorbidity of MG and ALS, which may have resulted from a common aberrant immune process and to emphasize the importance of detailed clinical analysis and adequate diagnostic methods essential for correct diagnosis and treatment. Only several cases of coexistence of MG and ALS have been described in medical literature. Exploring the pathogenetic association between MG and ALS may lead to dysregulation of thea immune system. Deficiency of T-regulatory cells, increased activity of atrophy-related atrogenes, anomalies of neuronal nitric oxide synthase can be found in both diseases. Immunoglobulin isolated from ALS patients can affect neuromuscular junction and activate AChRs, which plays an important role in the innervation and re-innervation of muscle fibers. Immunoglobulin also changes the function of Ca2+ channels. Blood level of circulatory Heat Shock Protein 70 (HSP70) antibodies in MG patients is elevated. HSP70 maintains normal conformation of cell proteins. Conversely, HSP70 antibodies cause HSP70's dysfunction and therefore, abnormal protein synthesis, which can be the main reason of neurodegenerative diseases, such as ALS. Experimental evidence indicates, that muscle and neuromuscular junctions may be initial targets of ALS. According to the "dying-back" hypothesis, neuromuscular junction damage and failure in MG patients may precede lower and upper motor neuron loss, and thus increase risk of developing ALS. Pathogenetic mechanisms of MG and ALS are the subjects of further studies. Refining the etiology of these two diseases will answer the question whether it is a transformation or a coexistence of MG and ALS in our case. The presented case demonstrates, that in spite of meeting all diagnostic criteria it is, sometimes, impossible to make the correct diagnosis. Only a detailed clinical analysis and adequate diagnostic methods contribute to correct diagnosis and adequate therapy.
作者报告了一例75岁男性患者,其具有肌萎缩侧索硬化症(ALS)典型的临床和神经肌电图体征,这些体征在其被诊断为全身型重症肌无力(MG)4年后出现。本文的目的是评估MG和ALS发病机制综合合并存在的可能性,这可能源于共同的异常免疫过程,并强调详细的临床分析和适当的诊断方法对于正确诊断和治疗的重要性。医学文献中仅描述了几例MG和ALS共存的病例。探索MG和ALS之间的发病机制关联可能导致免疫系统失调。在这两种疾病中都可发现调节性T细胞缺乏、与萎缩相关的萎缩基因活性增加、神经元型一氧化氮合酶异常。从ALS患者分离出的免疫球蛋白可影响神经肌肉接头并激活乙酰胆碱受体,这在肌纤维的神经支配和再支配中起重要作用。免疫球蛋白还会改变钙离子通道的功能。MG患者循环热休克蛋白70(HSP70)抗体的血液水平升高。HSP70维持细胞蛋白质的正常构象。相反,HSP70抗体导致HSP70功能障碍,从而导致蛋白质合成异常,这可能是诸如ALS等神经退行性疾病的主要原因。实验证据表明,肌肉和神经肌肉接头可能是ALS的初始靶点。根据“逆行性变性”假说,MG患者的神经肌肉接头损伤和功能障碍可能先于上下运动神经元丧失,从而增加患ALS的风险。MG和ALS的发病机制是进一步研究的课题。明确这两种疾病的病因将回答在我们的病例中是MG转变为ALS还是两者共存的问题。所呈现的病例表明,尽管符合所有诊断标准,但有时仍无法做出正确诊断。只有详细的临床分析和适当的诊断方法有助于正确诊断和适当治疗。